ENDRA Life Sciences (NDRA) Price to Sales (2017 - 2018)
ENDRA Life Sciences' (NDRA) quarterly Price to Sales came in at 57822.0 in Q1 2018, down 15.54% quarter-over-quarter from 68462.15 in Q4 2017.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Price to Sales (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Price to Sales for 2 consecutive years, with 57822.0 the latest figure, recorded in Q1 2018.
- On a quarterly basis, Price to Sales changed N/A year-over-year to 57822.0 in Q1 2018; TTM through Dec 2018 was 38307.82, a 2772.25% increase from a year earlier, with the FY2018 full-year figure at 38307.82, up 2772.25% from the prior year.
- Price to Sales was 57822.0 for Q1 2018 at ENDRA Life Sciences, down from 68462.15 in the prior quarter.
- Over five years, Price to Sales peaked at 68462.15 in Q4 2017 and troughed at 1515.15 in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 57,822.00 |
| Dec 31, 2017 | 68,462.15 |
| Sep 30, 2017 | 1,515.15 |
| Jun 30, 2017 | 5,757.99 |